New Clinical Trial Map Available in the EU

A newly launched clinical trial map is now accessible via the public website of the Clinical Trials Information System (CTIS) (CTIS Trial Map). This tool is designed to enhance access to clinical research by offering patients and healthcare professionals a user-friendly way to locate clinical trials in their region. The map provides real-time, comprehensive information about ongoing studies across the European Union (EU).

Enhancing Search and Accessibility
Leveraging the public data available in CTIS, the interactive map improves the way users navigate and find trial-related information. It enables searches by geographic location and medical condition, with support for layperson-friendly language. Additionally, an integrated autocorrect feature ensures that even misspelled queries yield relevant suggestions. Each search result includes investigator contact details, allowing potential participants to inquire about enrolment opportunities. Initially available in English, the map will be expanded to include more EU languages in upcoming updates.

Part of the ACT EU Initiative
This initiative is a key component of the Accelerating Clinical Trials in the European Union (ACT EU) workplan for 2025-2026 (Workplan Document). It was developed in response to stakeholder requests for a more patient-friendly dashboard within CTIS, making clinical trials more accessible to the public.

Webinar Recording Now Available
A public webinar hosted by the European Medicines Agency (EMA) provided a live demonstration of the new clinical trial map. The recorded session is now available on the official website for those who wish to learn more about its features and functionalities (Webinar Recording).

Ensuring Transparency in Clinical Trials
CTIS offers a publicly searchable database (CTIS Database) that helps healthcare professionals, patients, and citizens access trial-related information with high transparency. The responsibility for authorizing and overseeing clinical trials lies with the EU/EEA Member States, while the European Medicines Agency (EMA) maintains CTIS. The European Commission ensures the implementation of the Clinical Trials Regulation.